AHA Coding Clinic® for HCPCS - 2016 Quarter 4; Ask the Editor
IV formulation for Stelara
Is there a significant difference between an intravenous (IV) versus subcutaneous (SQ) formulation for Stelara. Should the IV formulation for Stelara be submitted under HCPCS code J3357 or HCPCS code J3590 ? What is the correct code for an IV formulation for Stelara? ...
Note: The following article synopsis was NOT provided by the AHA. It was created by Find-A-Code/innoviHealth.
Article Overview
This short coding article addresses how Stelara was reported before and after a January 1, 2017 HCPCS change, with focus on whether the intravenous formulation should be reported under a product-specific code or an unclassified code. It is relevant to coders, billers, and reimbursement staff who work with specialty drug reporting and need to understand the scope of the HCPCS update.
Why This Topic Matters
Drug coding changes can affect claim accuracy, denied claims, and reporting consistency. This article helps readers identify the applicable HCPCS context for Stelara around the 2017 descriptor revision.
What You Will Learn
How the article frames the question of intravenous versus subcutaneous Stelara billing
What coding issue changed effective January 1, 2017
Why the article is relevant to HCPCS drug reporting review
How the article situates the Stelara coding question in a time-based context
Quick, Current, Complete - www.findacode.com